Lomotil and Jugular vein thrombosis - a phase IV clinical study of FDA data

Summary:

Jugular vein thrombosis is reported as a side effect among people who take Lomotil (atropine sulfate; diphenoxylate hydrochloride), especially for people who are male, 50-59 old, also take Neurontin, and have Pain.

The phase IV clinical study analyzes which people have Jugular vein thrombosis when taking Lomotil. It is created by eHealthMe based on reports of 18,891 people who have side effects when taking Lomotil from the FDA, and is updated regularly.

What is Lomotil?

Lomotil has active ingredients of atropine sulfate; diphenoxylate hydrochloride. It is often used in diarrhea. eHealthMe is studying from 19,184 Lomotil users. Check the latest studies of Lomotil.

What is Jugular vein thrombosis?

Jugular vein thrombosis (clot in jugular vein) is found to be associated with 424 drugs and 509 conditions by eHealthMe. Check the latest studies of Jugular vein thrombosis.

On Jul, 11, 2026

18,891 people reported to have side effects when taking Lomotil.
Among them, 22 people (0.12%) have Jugular vein thrombosis.

Could Lomotil cause Jugular vein thrombosis?

Among these 22 people:

What is the gender of people who have Jugular vein thrombosis when taking Lomotil? *

female: 22.73 %
male: 77.27 %

What is the age of people who have Jugular vein thrombosis when taking Lomotil? *

What are other drugs people take besides Lomotil? *

What are other side effects people have besides Jugular vein thrombosis? *

Stress And Anxiety: 17 people, 77.27%
Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 16 people, 72.73%
Cellulitis (infection under the skin): 16 people, 72.73%
Depression: 16 people, 72.73%
Oedema Peripheral (superficial swelling): 16 people, 72.73%
Leukocytosis (increased white blood cells): 16 people, 72.73%
Joint Pain: 16 people, 72.73%
Drug Withdrawal Syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation): 16 people, 72.73%
Fatigue (feeling of tiredness): 15 people, 68.18%
Dehydration (dryness resulting from the removal of water): 15 people, 68.18%

What are the existing conditions these people have? *

Pain: 4 people, 18.18%
Stress And Anxiety: 2 people, 9.09%
Sleep Disorder: 2 people, 9.09%
Headache (pain in head): 2 people, 9.09%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 9.09%
Depression: 2 people, 9.09%
Back Pain: 2 people, 9.09%
Allergic Sinusitis: 2 people, 9.09%
Premenstrual Syndrome: 1 person, 4.55%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Lomotil and have Jugular vein thrombosis?

- Check whether Jugular vein thrombosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lomotil:

Lomotil (19,184 reports)

Jugular vein thrombosis treatments and more:

Jugular vein thrombosis (2,609 reports)

How severe was Jugular vein thrombosis and when was it recovered:

Jugular vein thrombosis in Lomotil

Expand to all the drugs that have ingredients of atropine sulfate; diphenoxylate hydrochloride:

Jugular vein thrombosis and drugs with ingredients of atropine sulfate; diphenoxylate hydrochloride (23 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lomotil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Jugular vein thrombosis:

Jugular vein thrombosis (424 drugs)

Browse all the conditions that are associated with Jugular vein thrombosis:

Jugular vein thrombosis (509 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on atropine sulfate; diphenoxylate hydrochloride (the active ingredients of Lomotil) and Lomotil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.